Abstract
People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self- reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a ‘cannabis clinic’ doctor, incurring an initial consultation cost of $100–$200+ (10.2% Medicare bulk- billed) and median cannabinoid medicine costs of $300AUD per month. Cost was a major barrier to access, necessitating reducing dosage (76.1%) and/or consuming illicit cannabis (42.9%), despite a prescription. Most (77%) medical consumers used two or more cannabis products, with delta- 9- tetrahydrocannabinol predominant oil and flower products most frequently prescribed.
Original language | English |
---|---|
Pages (from-to) | 411-415 |
Number of pages | 5 |
Journal | Australian and New Zealand Journal of Obstetrics and Gynaecology |
Volume | 64 |
Issue number | 4 |
DOIs | |
Publication status | Published - Aug 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Open Access - Access Right Statement
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.© 2024 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.Notes
WIP in RDKeywords
- administration method
- cannabis
- CBMP
- chronic pain
- dose
- endometriosis
- insurance